MPM Capital is a leading investment company in the field of biotechnology, bringing together nearly thirty years of expertise to establish and invest in enterprises dedicated to translating scientific advancements into treatments for significant illnesses. With its exceptional team and extensive knowledge in scientific exploration, clinical advancement, and business development, MPM aims to drive original advances in medical treatment that revolutionize the lives of patients. MPM provides funding across the biotech sector through early-stage investment capital, as well as through impact and public equity offerings via its partner organization BioImpact Capital.
Mpm Capital
Headquarters
United States of America